| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |